ea0098c35 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023
Lan Wong PA-C, Yee
, MD, PhD. James Thomas
Background: Metastatic paragangliomas (PGL) and pheochromocytomas (PCC) are rare neuroendocrine diseases with an incidence of 2 to 8 people per million, a prevalence between 1:2500 and 1:6500 and a strong hereditary disposition. However, due to the rarity of the disease, there is relatively limited data on treatment options, including radionuclide therapy using radioisotope analogs of MIBG and dotatate. There are a few published small series on clinical benefits of treating PG...